Home Global Business issues Services Industries Research & insights About us Careers PwC Open University United States International PwC Sites HRI's top health industry issues of 2016 Learn more 1 2 3 4 5 6 Major shift ahead in how FDA regulates drug quality Parts of the pharmaceutical industry continue to struggle with drug quality. A major shift in the way the FDA oversees drug quality could pose new challenges for companies with inadequate control over their manufacturing facilities and supply chains. Read more on the FDA’s changing regulation of drug quality. Three years in, the ACA marketplace shows modest premium growth, fewer plan options and continued competition Carriers are refining their product offerings as they become more knowledgeable about who they are insuring and how to navigate a more tightly regulated market. With real money left to capture, there is still opportunity for insurers to enter the market or expand their footprints. Explore HRI’s analysis of the ACA marketplace three years in. Top health industry issues of 2016: Thriving in a New Health Economy 2016 will be a year of firsts for healthcare consumers, organizations and new entrants as innovative tools and services enter the New Health Economy. HRI’s annual Top health industry issues report highlights the forces that are expected to have the most impact on the industry in the coming year, with a glance back at key trends from the past decade. Visit Top health industry issues of 2016. Primary care: Poised for a makeover in the New Health Economy Forecasts of physician shortages are based on outdated care delivery models. In the New Health Economy, with purchasers demanding greater value, do-it-yourself consumers and integrated care teams armed with a black bag of virtual tools are poised to reinvent primary care and close the gap. Visit HRI's future of primary care website to learn more. Healthcare's Alternative Payment Landscape As public and private insurers move away from traditional fee-for-service payments, healthcare organizations are struggling to make the leap. Market share, regional characteristics and an organization's mission and culture all play a role. How and when to make the leap? 21st Century Pharmaceutical Collaboration: The Value Convergence New collaborations pairing drug makers with insurers, health systems, patient groups and technology firms are reconfiguring drug R&D and commercialization. Shared data is shaping drug development and demonstrating health outcomes to create value for patients and industry. 21st Century Pharmaceutical Collaboration: The Value Convergence Medical cost trend: Behind the numbers 2016 Today, 10 years after HRI first issued its projection for the coming year’s medical cost trend, the healthcare growth rate has slowed. But, despite the improved growth rate, medical inflation still outpaces general economic inflation. In this year’s report, HRI identifies the major trends of the last decade, including more consumer cost sharing, greater use of technology and shifting care from inpatient settings to less traditional retail clinics. Visit HRI’s Medical cost trend: Behind the numbers website Download HRI’s new report, Medical cost trend: Behind the numbers 2016 Contacts Kelly Barnes US Health Industries and Global Health Industries Consulting Leader Tel: +1 (214) 754 5172 Email Meet the HRI team Watch our videos on key healthcare issues Video: William Gillespie, MD (Chief Medical Officer - Emblem Health) discusses three keys to creating sustainable success. Visit PwC's US Health Industries Healthcare's new entrants: Who will be the industry's Amazon.com? New entrants are poised to draw billions of dollars in revenue from traditional organizations while building lucrative new markets in the burgeoning New Health Economy™. Here's how. See how new entrants are reshaping the health sector Trending Today Top health industry issues of 2016 Behind the numbers: 2016 health care and medical cost trends report Health Research Institute Health Industries Health Services: healthcare payers and providers Pharmaceutical and Life Sciences New Health Economy Vision for the Future Pharmaceutical and Life Sciences Deals Insights Quarterly Social media Health Research Institute (HRI) About HRI New Health Economy Top healthcare issues Affordable Care Act Health technology and innovation Pharma and life sciences HRI library HRI regulatory center US Health industries Global Healthcare Download our 365 app today. As businesses think through the cost of health coverage in a post-ACA world, federal taxes are a big consideration. See why. Press room Alumni Other sites US offices Contact us © 2015-2016 PwC. All rights reserved. PwC refers to the US member firm or one of its subsidiaries or affiliates, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details. Privacy Cookies info Legal Site provider Site map